CNIL (France) - 2023-097: Revision history

From GDPRhub

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

6 December 2023

2 November 2023

  • curprev 19:5919:59, 2 November 2023R e talk contribsm 18,375 bytes +4 Initial contributor Tag: Visual edit
  • curprev 15:1115:11, 2 November 202392.184.118.171 talk 18,371 bytes +566 →‎Comment: the CNIL gives its approval to many medical research studies like this every week; they not always publish them. the reason the CNIL has to give so many approvals is because they created the rule that obliges organisations to ask the CNIL: if you don't comply with their methodologies of reference, you cannot start the medical research/registry/cohort etc before you got approval from the CNIL and this can take several months. To my knowledge, they are the only DPA in Europe to have Tag: Visual edit

31 October 2023

30 October 2023

27 October 2023

  • curprev 19:5819:58, 27 October 2023R e talk contribs 17,071 bytes +17,071 Created page with "{{DPAdecisionBOX |Jurisdiction=France |DPA-BG-Color= |DPAlogo=LogoFR.png |DPA_Abbrevation=CNIL |DPA_With_Country=CNIL (France) |Case_Number_Name=2023-097 |ECLI= |Original_Source_Name_1=Légifrance - le service public de la diffusion du droit |Original_Source_Link_1=https://www.legifrance.gouv.fr/cnil/id/CNILTEXT000048225390?page=1&pageSize=10&query=2016%252F679&searchField=ALL&searchType=ALL&sortValue=DATE_DECISION_DESC&tab_selection=cnil&typePagination=DEFAULT |Origi..." Tag: submission [1.0]